Pseudohyperkalemia from Thrombocytosis
Yes, high platelet counts cause falsely elevated serum potassium (pseudohyperkalemia), not true hyperkalemia—this is a critical distinction that prevents unnecessary and potentially dangerous treatment. 1, 2
Mechanism and Clinical Significance
Pseudohyperkalemia occurs when platelets release intracellular potassium during the clotting process in vitro, artificially elevating serum potassium measurements while plasma potassium remains normal. 1, 3
Key characteristics:
- Serum potassium exceeds plasma potassium by more than 0.4 mmol/L 3
- Plasma potassium levels remain normal despite elevated serum values 2, 4
- No true metabolic disturbance exists—this is purely a laboratory artifact 2
Prevalence and Platelet Count Thresholds
The relationship between platelet count and pseudohyperkalemia is dose-dependent:
- Hyperkalemia incidence increases from 9% at platelet counts <250×10⁹/L to 34% when platelets exceed 500×10⁹/L 2
- Traditionally described at extreme thrombocytosis (>1,000×10⁹/L), but occurs at much lower elevations 2, 4
- A highly significant positive correlation exists between platelet count and serum potassium (R=0.998) 4
Populations at Highest Risk
Myeloproliferative disorders show the highest rates of pseudohyperkalemia:
- Primary thrombocythemia: 75.7% of patients 4
- Polycythemia vera: 75% of patients 4
- Myelofibrosis: 50% of patients 4
- Reactive thrombocytosis: 34.5% of patients 4
Overall, 60% of all patients with thrombocytosis from any cause demonstrate pseudohyperkalemia 4
Diagnostic Algorithm
When encountering elevated serum potassium with thrombocytosis, follow this sequence:
Check platelet count immediately—if elevated, suspect pseudohyperkalemia 1, 3
Assess for true hyperkalemia causes (only if plasma potassium is also elevated) 5, 6:
Obtain ECG—pseudohyperkalemia will NOT show ECG changes (peaked T waves, widened QRS) 5, 6
Critical Management Pitfalls
Do NOT treat pseudohyperkalemia as true hyperkalemia—this can cause dangerous iatrogenic hypokalemia. 3, 4
Common errors to avoid:
- Initiating aggressive hyperkalemia treatment (calcium, insulin/glucose, dialysis) based solely on serum potassium without checking plasma levels 3
- Altering dialysis prescriptions in renal patients with thrombocytosis without confirming true hyperkalemia 3
- Failing to recognize pseudohyperkalemia leads to unnecessary anxiety, testing, and potentially harmful interventions 8, 4
The European Heart Journal emphasizes ruling out pseudohyperkalemia before treatment, as failing to do so is a major pitfall in hyperkalemia management 5
When Pseudohyperkalemia Signals Underlying Disease
Persistent unexplained pseudohyperkalemia may be the first clue to an undiagnosed myeloproliferative disorder. 8
- If thrombocytosis is newly discovered during hyperkalemia workup, immediate hematologic evaluation is warranted 8
- Essential thrombocythemia and other myeloproliferative disorders are commonly diagnosed this way 8, 4
- Normalizing platelet counts (through treatment of the underlying disorder) resolves the pseudohyperkalemia 8